Annual report pursuant to Section 13 and 15(d)

SELECTED FINANCIAL STATEMENT LIABILITIES (Details)

v3.24.2
SELECTED FINANCIAL STATEMENT LIABILITIES (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Accounts payable:    
Clinical and regulatory expenses $ 696 $ 361
Professional fees 721 626
Selling expenses 1,498 1,363
Manufacturing costs 914 650
Non-employee director compensation 766 484
Other vendors 1,292 301
Total accounts payable 5,887 3,785
Accrued interest payable, related parties 542 144
Accrued interest payable 3,122 2,381
Accrued expenses:    
Payroll expenses 1,270 1,263
Government rebates and other rebates 5,881 5,536
Due to customers 844  
Other accrued expenses 179 440
Total accrued expenses 8,174 7,239
Total accounts payable and accrued expenses $ 17,725 $ 13,549